Physician profile
Danae E Bell
NPI 1902553761
$1,296.61
in general payments reported to CMS, 2019-2025
14 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $336 · 2023: $483 · 2024: $146 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $378.73 | 2023-2025 | Veozah |
| Aspira Women'S Health INC | $187.57 | 2022 | |
| Sumitomo Pharma America, INC. | $132.66 | 2023-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $130.55 | 2022-2024 | Coolseal Generator, Acessa Provu System, Aptima |
| Acella Pharmaceuticals, LLC | $130.01 | 2023 | NP Thyroid 60 |
| Exeltis, USA INC. | $76.72 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $70.79 | 2022-2025 | |
| Biogen, INC. | $47.22 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $36.65 | 2022 | |
| Organon LLC | $36.60 | 2025 | Nexplanon, Nuvaring |
| Sanofi Pasteur INC. | $25.36 | 2022 | |
| Mayne Pharma Commercial LLC | $17.20 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $13.79 | 2023 | Seglentis |
| Exact Sciences Corporation | $12.76 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danae Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.